GC167 I Feel Very Nervous Anxiety Disorders
Anxiety disorders are a group of mental health conditions characterized by excessive, persistent fear, worry, or nervousness that causes significant distress and impairment in daily functioning.
I Feel Very Nervous: Anxiety Disorders
Lecture Map
Anxiety is the most common category of psychiatric disorders. It is a normal emotion—a survival mechanism mediated by the limbic system—that becomes pathological when it is disproportionate, persistent, and functionally impairing. This lecture walks from neurobiology → clinical manifestations → specific disorder criteria → management, giving you the scaffolding to diagnose and treat the major anxiety-related disorders: Generalised Anxiety Disorder (GAD), Panic Disorder, Phobic Anxiety Disorders (Specific, Social, Agoraphobia), and Obsessive-Compulsive Disorder (OCD).
- The role of the limbic system in emotional response and anxiety disorders
- Clinical manifestation of anxiety symptoms
- Common anxiety disorders
- Management of anxiety disorders
- Primary care: Anxiety disorders affect ~1 in 7 adults; > 50% are missed by doctors. Patients often present with somatic rather than psychological complaints [3].
- Exam relevance: Anxiety disorders are a recurring topic in Fourth Summative MCQs, EMQs, SAQs, and minicases. The AOS notes flag that "common" diagnoses like anxiety, PTSD, OCD, and adjustment disorder are frequently tested [7].
- Related GC lectures: GC 171 (Stress-related & OCD) [4], GC 164 (Depression), GC 165 (Sleep), GC 168 (Psychopharmacology), CFB PSY01-04.
Core Concepts and Mechanisms
The amygdala-based neurocircuit is central to anxiety. [1]
| Structure | Role in Anxiety |
|---|---|
| Amygdala | Registers the emotional significance of stimuli; develops emotional memory. The "alarm centre"—fires in response to threat cues. |
| Hippocampus | Contextual memory—helps determine whether a stimulus is truly threatening based on past experience. Dysfunction → inability to "turn off" fear in safe contexts. |
| Medial Prefrontal Cortex | Cognitive control & manifestation of anxiety—exerts top-down inhibition on the amygdala. Impaired prefrontal control → excessive anxiety. |
| Hypothalamus & Brain Stem Nuclei | Somatic manifestation of anxiety—activates the HPA axis and autonomic nervous system (sympathetic fight-or-flight response). |
| Thalamus | Sensory relay—passes incoming stimuli to the amygdala (fast, crude "low road") and cortex (slow, refined "high road"). |
| Cingulate Gyrus | Emotion regulation and error detection; connects to prefrontal cortex. |
| Fornix, Parahippocampal Gyrus | Part of the limbic circuit connecting hippocampus to hypothalamus. |
Why this matters from first principles: In normal fear, a threatening stimulus is detected by the amygdala → hypothalamus activates the sympathetic nervous system → heart rate ↑, sweating, hyperventilation etc. The prefrontal cortex then evaluates the threat and suppresses the amygdala if the danger is not real. In anxiety disorders, this top-down regulation is impaired—the amygdala is hyperactive, the prefrontal cortex is hypoactive, and the hippocampus fails to properly contextualise safety signals.
Dysregulation of GABA, norepinephrine, and serotonin systems causes anxiety disorder. [1]
| Neurotransmitter System | Normal Function | Role in Anxiety |
|---|---|---|
| GABA | Inhibitory neurotransmitter; suppresses other NT systems (serotonin, NE, dopamine) | ↓GABA activity → loss of inhibition → neuronal over-excitability → anxiety. This is why benzodiazepines (GABA-A agonists) are effective anxiolytics. |
| Norepinephrine (NE) | Mediates autonomic arousal | ↑NE → autonomic arousal & somatic symptoms of anxiety (palpitations, sweating, tremor). Locus coeruleus over-firing. This is why beta-blockers help somatic symptoms. |
| Serotonin (5-HT) | Regulates appetite, energy, sleep, mood, libido, cognitive function | Dysregulation → anxiety plus mood/sleep/appetite disturbance. This is why SSRIs are first-line for anxiety disorders (they take weeks to work because they induce downstream receptor changes). |
Why SSRIs for anxiety, not just depression?
SSRIs increase serotonin availability at the synapse. Over weeks, this leads to desensitisation of inhibitory 5-HT1A autoreceptors on the raphe nuclei, which ultimately increases overall serotonergic tone. In anxiety, this enhanced 5-HT signalling strengthens prefrontal cortex inhibition of the amygdala. This is why SSRIs take 2-4 weeks to work and may initially worsen anxiety (the initial increase in synaptic 5-HT can be stimulating before autoreceptor desensitisation occurs).
Clinical Manifestation of Anxiety Disorders
Psychological symptoms: worrying thoughts, fearful anticipation, irritability, restlessness, sensitivity to noise, difficulty in concentration, subjective poor memory. [1]
High Yield
Somatic presentation is common. Co-morbidity is common. [1] — Many patients present to primary care with physical complaints, NOT psychiatric complaints. You must think of anxiety in any patient with unexplained multi-system somatic symptoms.
| System | Symptoms |
|---|---|
| GI tract | Dry mouth, swallowing difficulty, epigastric discomfort, excessive belching, frequent loose bowel motions |
| Respiratory | Chest constriction, breathing difficulty, hyperventilation |
| Cardiovascular | Palpitation, chest discomfort |
| Genitourinary | Frequency of micturition, erectile failure, lack of libido, increased menstrual discomfort |
| CNS | Tinnitus, blurring of vision, dizziness, headache, muscle aches and stiffness, tremulous hands |
| Others | Disturbed sleep, unpleasant dreams |
Why somatic symptoms occur: The autonomic nervous system (sympathetic activation via hypothalamus/brainstem) produces all these physical manifestations. Patients may undergo extensive medical workups (cardiac, GI, respiratory) before anxiety is considered.
The lecture provides a central diagram showing the spectrum of anxiety-related disorders. [1]
Panic Disorder
Panic Disorder: Severe anxiety attack — palpitation, chest pain, choking sensation, dizziness, fear of dying, losing control, or going mad. [1]
Key characteristics:
- Unpredictable & sudden onset — not restricted to any particular situation, no obvious precipitating factor [1]
- Recurrent attacks
- Persistent fear of having another attack (anticipatory anxiety)
- Subsequently avoid that situation → may develop phobic symptoms
- May be agoraphobic if attacks occur in various situations [1]
- May become demoralised and depressed [1]
An abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, and during which time four (or more) of the following symptoms occur: [1]
| Physical Symptoms | Cognitive/Dissociative Symptoms |
|---|---|
| Palpitations, pounding heart, accelerated HR | Derealization or depersonalization |
| Sweating | Fear of losing control or going crazy |
| Trembling or shaking | Fear of dying |
| Shortness of breath or smothering | |
| Feeling of choking | |
| Chest pain or discomfort | |
| Nausea or abdominal distress | |
| Feeling dizzy, unsteady, lightheaded, or faint | |
| Chills or heat sensations | |
| Paresthesias |
Note: A panic attack is not itself a diagnosis—it is a specifier. The diagnosis of Panic Disorder requires the recurrence criteria below.
- Recurrent unexpected panic attacks
- At least one attack followed by ≥1 month of one or both:
- Persistent concern about having additional attacks or their consequences
- A significant maladaptive change in behaviour related to the attacks (e.g. avoiding exercise, leaving home)
- Not due to direct physiological effects of a substance or general medical condition
- Not better accounted for by another mental disorder
High Yield Exam Point
The key discriminator for panic disorder is that the attacks are unexpected (uncued)—they are NOT restricted to any particular situation. If attacks only occur in social situations → consider social phobia. If only in crowded/enclosed places → consider agoraphobia. This is a commonly tested distinction.
- Depression
- Other anxiety disorders (e.g. agoraphobia)
- Alcohol and drug abuse
| Category | Examples |
|---|---|
| Physical disorders | Epilepsy, thyroid disease, cardiac disease, vestibular dysfunction, pheochromocytoma |
| Substance abuse | Intoxication or withdrawal |
| Other anxiety disorders | GAD, phobias |
Why these DDx matter: Pheochromocytoma causes episodic catecholamine surges that perfectly mimic panic attacks (paroxysmal hypertension, palpitations, sweating, tremor). Thyrotoxicosis causes chronic sympathetic overactivity. Temporal lobe epilepsy can produce feelings of dread and autonomic symptoms. Always exclude organic causes before diagnosing panic disorder.
Management [1]
- Interpretation of body sensation — helping patients understand that their chest pain is from hyperventilation, not a heart attack
- Understanding physiological response to fear — psychoeducation about fight-or-flight
- Relaxation techniques
- First-line: SSRIs (start low, go slow—initial worsening of anxiety)
- Alternatives: TCAs (especially imipramine for panic disorder [1]), SNRIs
- Acute relief: Benzodiazepines (short-term only, risk of dependence)
- Adjunct: Beta-blockers for somatic symptoms
Phobic Anxiety Disorders
Anxiety is provoked in the presence or anticipation of a specific object: Animals, Heights, Thunders, Darkness, Blood etc. Tendency to avoid the stimulus. Severe distress or functional impairment. [1]
DSM-5 Criteria [1]
- Marked fear or anxiety about a specific object or situation
- Almost always provokes immediate fear or anxiety
- Actively avoided or endured with intense fear
- Out of proportion to actual danger and sociocultural context
- Persistent, typically ≥6 months
- Causes clinically significant distress or functional impairment
- Not better explained by another mental disorder
Special note on Blood-Injection-Injury (BII) phobia: Unlike other phobias where the autonomic response is sympathetic activation (tachycardia, hypertension), BII phobia uniquely causes a vasovagal response (initial tachycardia then profound bradycardia and hypotension → fainting). This is why patients with needle phobia actually faint rather than just feel anxious.
Away from home. In crowds or situations they cannot leave easily that provoke anxiety and avoidance: Buses, Trains, MTR, Supermarket, Queue, Hairdresser's chair, Cinema. Need to be accompanied. Severe → Housebound. [1]
DSM-5 Criteria [1]
- Marked fear or anxiety about TWO (or more) of five situations:
- Using public transportation
- Being in open spaces
- Being in enclosed places
- Standing in line or being in a crowd
- Being outside of the home alone
- Fears situations because escape might be difficult or help might not be available
- Almost always provokes fear/anxiety
- Actively avoided, require companion, or endured with intense fear
- Out of proportion, persistent ≥6 months, causes significant distress/impairment
- Not better explained by another mental disorder
Agoraphobia ≠ just 'fear of open spaces'
Agoraphobia literally means "fear of the marketplace" but it is really about fear of situations where escape is difficult or help unavailable if panic symptoms develop. In DSM-5, agoraphobia is a separate diagnosis from panic disorder (you can have agoraphobia without panic disorder, and vice versa). In ICD-10, it is specified "with or without panic disorder." [2]
Anxious in situations observed, criticized, embarrassment or humiliation. Speak in small group. Introduced to stranger. Eat in public, write in public. Fear of angry, rejecting face, avoid eye-contact. Blushing and trembling. [1]
DSM-5 Criteria [1]
- Marked fear about social situations with possible scrutiny by others
- Fears acting in a way or showing anxiety symptoms that will be negatively evaluated
- Almost always provokes fear/anxiety
- Avoided or endured with intense fear
- Out of proportion, persistent ≥6 months
- Causes clinically significant distress/impairment
- Not attributable to substance or medical condition
- Not better explained by another mental disorder
- If another medical condition present, fear is clearly unrelated or excessive
Key point: The fear is specifically about being negatively evaluated by others, not about the situation itself. This distinguishes social phobia from agoraphobia (where the fear is about being unable to escape).
- Depression
- Alcohol and drug abuse
- Panic disorder with agoraphobia
| DDx for anxiety symptoms | DDx for avoidance features |
|---|---|
| Physical disorder, substance abuse | Personality disorder, psychosis, depression |
Why avoidance DDx matters: Avoidant personality disorder shows pervasive social avoidance but from a core sense of inadequacy (not discrete fear episodes). Psychosis may cause avoidance due to persecutory delusions. Depression causes withdrawal from activities due to anhedonia, not fear.
Management of Phobic Disorders [1]
- Targeting the avoidance (hierarchy list) — construct a graded list of feared situations from least to most anxiety-provoking
- Exposure techniques: Graduated, repeated, prolonged, clear tasks
- Real-life and imaginal exposure
- Home-based, relative support
- Relaxation exercise
- Social phobia specifically:
- Social skill training
- Cognitive treatment for fear of negative evaluation from others
Generalised Anxiety Disorder (GAD)
Excessive worries and anxiety. Free floating anxiety. Apprehensive expectation. Psychological & somatic manifestation of anxiety occur most of the time. [1]
"Free-floating" anxiety means the anxiety is not tied to any particular object, situation, or event—it just "floats" around, attaching to whatever is currently in the person's mind. This distinguishes GAD from phobias (situational) and panic disorder (episodic).
1. Excessive anxiety & worry, occurring more days than not for at least 6 months, about a number of events or activities [1]
2. The person finds it difficult to control the worry [1]
3. Associated with ≥3 of the following 6 symptoms: [1]
| GAD Symptoms (≥3 required) | Mnemonic: "WIRED-M" |
|---|---|
| Restlessness or feeling keyed up/on edge | Wired |
| Being easily fatigued | Irritable |
| Difficulty concentrating or mind going blank | Restless |
| Irritability | Easily fatigued |
| Muscle tension | Difficulty concentrating |
| Sleep disturbance | Muscle tension |
4. Causes clinically significant distress & functional impairment [1] 5. Not due to direct physiological effects of substance or medical conditions [1] 6. Not explained by another mental disorder [1]
2/3 of GAD patients have other psychiatric diagnoses [1]
- Depression
- Other anxiety disorders (e.g. panic, social anxiety)
- Personality disorder (e.g. anankastic, paranoid, avoidant) — note "anankastic" = obsessive-compulsive personality disorder
- Alcohol and drug abuse
| DDx | Discriminating Feature |
|---|---|
| Depression | Depressive rumination focuses on past events with guilt/worthlessness; GAD worry focuses on future events. Early morning waking, diurnal mood variation, and suicidal thoughts are uncommon in pure GAD. |
| Panic Disorder | Unexpected (uncued) panic attacks are unusual in GAD. Panic patients fear acute catastrophe ("I'm having a heart attack"); GAD patients have persistent, diffuse worry. |
| Social Anxiety | Worry is mainly about social evaluation in SAD; in GAD, worry occurs regardless of social context. |
| OCD | OCD obsessions tend to be about primal fears (contamination, harm) with ritualistic compulsions; GAD worries are about everyday concerns. |
| Hypochondriasis | Principally about illness; GAD about multiple topics. |
| Physical illness | Thyrotoxicosis, hypoglycaemia, pheochromocytoma, cardiac arrhythmia, COPD/asthma, Cushing's disease [2] |
The GAD-7 is a validated 7-item self-report questionnaire. Each item scored 0-3 (not at all → nearly every day). Total score interpretation:
| Score | Severity |
|---|---|
| 0–4 | Minimal anxiety |
| 5–9 | Mild anxiety |
| 10–14 | Moderate anxiety |
| 15–21 | Severe anxiety |
High Yield - GAD-7 Score of 10
A GAD-7 score of 10 = Moderate Anxiety. This was directly tested in the 2024 Fourth Summative MCQ Q77 [10]. Know these cut-offs.
Obsessive-Compulsive Disorder (OCD)
Note: In DSM-5, OCD is classified separately from anxiety disorders (under "Obsessive-Compulsive and Related Disorders"). However, the lecture includes it within the anxiety spectrum, and it is taught in this context for the exam.
Recurrent, compulsive nature. Thoughts, impulses, images, ruminations or doubts (obsession). Themes: dirt, contamination, aggression, illness, religion. Stereotyped behaviour (compulsion): Checking, cleaning, counting, slowness. Maintained insight & regarded as senseless. Presence of resistance. [1]
Key conceptual points:
- Obsessions are ego-dystonic (the patient recognises them as unwanted and distressing—they are NOT delusional)
- Compulsions are performed to reduce the anxiety caused by obsessions, but they are excessive and not realistically connected to preventing the feared outcome
- Insight is maintained — the patient knows these thoughts/behaviours are irrational
- Resistance — the patient tries to resist the obsessions/compulsions but fails
1. Contamination with cleaning 2. Doubt with checking 3. Precision & symmetry with ordering, counting, repeating, hoarding, slowness 4. Religious, sexual, aggressive obsession [1]
Obsessions (both required):
- Recurrent and persistent thoughts, urges, or images that are intrusive and unwanted, causing marked anxiety
- The individual attempts to ignore, suppress, or neutralize them
Compulsions (both required):
- Repetitive behaviours (hand washing, ordering, checking) or mental acts (praying, counting) that the individual feels driven to perform
- Aimed at preventing/reducing anxiety or preventing a dreaded event, but not connected in a realistic way or clearly excessive
Additional criteria:
- Time consuming (> 1 hour/day), or cause marked distress, or functional impairment [1]
- Not due to substance
- Not better explained by another mental disorder
Management of OCD [1]
- Psychoeducation
- Psychological support and reassurance
- Exposure and ritual prevention (ERP) — the gold standard: expose patient to anxiety-provoking stimulus while preventing the compulsive ritual
- Thought stopping and distraction for rumination
- Resistive thoughts only increase their occurrence — paradoxically, trying to suppress obsessional thoughts makes them worse (ironic process theory)
- Cognitive change: challenging catastrophic thinking:
- "If I don't do it perfectly, then I've done it horribly" → all-or-nothing thinking [1]
- "If something bad is going to happen, it is much more likely to happen to me or someone I love" → inflated responsibility [1]
- Modification of responsibility beliefs — consider evidence for less threatening alternative explanations [1]
- SSRIs (first-line) — often at higher doses than for depression
- Clomipramine (TCA) — specifically effective for OCD [1] — it is the most serotonergic TCA
- Augmentation with low-dose antipsychotics in refractory cases
Treatment of Anxiety Disorders: Summary [1]
Treatment of Anxiety Disorders: Supportive measures (Explanation, Reassurance), Psychological treatment (CBT), Medications (Antidepressants, Beta-blockers, Benzodiazepines, Buspirone, Pregabalin) [1]
| Drug Class | Specific Agents | Indication Notes |
|---|---|---|
| SSRI | Paroxetine, Citalopram, Escitalopram, Fluoxetine, Sertraline, Fluvoxamine | First-line for all anxiety disorders |
| SNRI | Venlafaxine, Duloxetine | Alternative first-line, especially GAD |
| TCA | Imipramine (panic disorder), Clomipramine (OCD) | Second-line; more side effects |
| MAOI | Phenelzine (phobia) | Dietary restrictions (tyramine), drug interactions |
| RIMA | Moclobemide (phobia) | Reversible—fewer dietary restrictions than classic MAOIs |
| Beta-blocker | Propranolol | Somatic symptoms (tremor, palpitations), performance anxiety |
| Benzodiazepines | Various | Short-term only; risk of dependence; avoid long-term |
| Buspirone | Buspirone | 5-HT1A partial agonist; GAD; no dependence; slow onset |
| Pregabalin | Pregabalin | α2δ calcium channel ligand; GAD; alternative to BZDs |
Exam Trap: BZDs in Long-Term Management
Benzodiazepines are effective acutely but should NOT be used for long-term management due to dependence, tolerance, and withdrawal. The AOS notes explicitly state: "Sleeping pills and BZD will not be used in long term management. Long term management includes antidepressants, antipsychotics, mood stabilizers." [7] This is a commonly tested principle.
| Disorder | Screening Question |
|---|---|
| Social Anxiety | "When you are in a situation where people can observe you, do you feel nervous and worry that they will judge you?" |
| GAD | "Do you consider yourself a worrier?" |
| Panic Disorder | "Have you ever experienced a panic attack?" |
| PTSD | "Have you ever had anything happen that still haunts you?" |
| OCD | "Do you get thoughts stuck in your head that really bother you, or need to do things over and over like washing your hands, checking things or counting?" |
Clinical Approach
- Presenting complaint: "What brings you in today?" — many present somatically
- Characterise the anxiety:
- Onset, duration, course (episodic vs continuous)
- Triggers (situational → phobia; none → panic disorder; generalised → GAD)
- Content of worry
- Associated symptoms: Psychological + somatic
- Avoidance behaviours: What situations does the patient avoid?
- Impact on function: Work, relationships, daily activities
- Comorbidities: Screen for depression (low mood, anhedonia), substance use, suicidal ideation
- Medical history & medications: Rule out organic causes
- Family history: Genetic contribution
- Premorbid personality: Anxious temperament, perfectionism
- Mental state examination (MSE): Appearance (restless, fidgety), mood (anxious), speech (pressured), thought content (worries, obsessions), perceptions (normal in pure anxiety)
- Physical examination: Thyroid (goitre, tremor, tachycardia), cardiovascular (arrhythmia), neurological
- Bloods: TFTs (thyrotoxicosis), glucose (hypoglycaemia), calcium
- ECG: Arrhythmia
- 24hr urinary catecholamines/metanephrines: Pheochromocytoma (if episodic hypertension + anxiety)
- Drug screen: If substance use suspected
It is not uncommon to have difficulties during interview with patients with anxiety disorder. [9]
| Helpful Techniques | Unhelpful Approach |
|---|---|
| Address the anxious feeling directly | Giving a diagnostic label (this can increase anxiety and stigma) [9] |
| Ask specific, structured questions | Vague, open-ended questions when patient is very anxious |
| Clarification and explanation | Dismissing symptoms |
| Feature | GAD | Panic Disorder | Agoraphobia | Social Phobia | Specific Phobia | OCD |
|---|---|---|---|---|---|---|
| Nature of anxiety | Continuous, free-floating | Episodic, spontaneous | Situational | Social situations | Specific object/situation | Obsessional thoughts |
| Trigger | None specific | None ("unexpected") | Crowds, public transport, open/enclosed spaces | Being observed/judged | Specific stimulus | Intrusive thoughts |
| Key fear | Multiple worries | Dying, losing control | Cannot escape, no help | Negative evaluation | The object itself | Consequences of not performing ritual |
| Avoidance | Minimal/diffuse | May develop agoraphobia | Yes—confined/crowded places | Social situations | The stimulus | Triggers of obsessions |
| Duration criterion | ≥6 months | ≥1 month of concern after attack | ≥6 months | ≥6 months | ≥6 months | Time-consuming ( > 1hr/day) |
| First-line Rx | SSRI/SNRI + CBT | SSRI + CBT | SSRI + Exposure | SSRI + CBT/Social skills | Exposure therapy | SSRI/Clomipramine + ERP |
This was tested in 2023 MCQ Q75. [9]
| Feature | More suggestive of Depression | More suggestive of GAD |
|---|---|---|
| Sleep | Early morning waking | Difficulty falling asleep (initial insomnia) |
| Appetite/Weight | Weight gain or loss (but weight gain is more specific to depression in the exam context) | Usually preserved |
| Concentration | Poor concentration (present in both) | Poor concentration (present in both) |
| Muscle tension | Less prominent | Key feature |
| Mood | Persistent low mood, anhedonia | Anxious, worried |
| Rumination content | Past failures, guilt, worthlessness | Future worries |
Past Paper Questions
Questions 23–27 (Common Psychological Presentations EMQ)
Options: A. Adjustment disorder, B. Bipolar disorder, C. Eating disorder, D. Generalised anxiety disorder, E. Major depressive disorder, F. Obsessive compulsive disorder, G. Panic disorder, H. Post-traumatic stress disorder, I. Substance use disorder, J. Undifferentiated psychological distress
- Q23: "Constant worrying even when there is no specific threat." → Answer: D. Generalised anxiety disorder — Free-floating anxiety about multiple concerns without specific trigger. [8]
- Q25: "Recurrent episodes of feeling short of breath as though one cannot get enough air in." → Answer: G. Panic disorder — Recurrent episodic breathlessness mimicking cardiopulmonary disease is classic panic. [8]
- Q27: "Constant need to check that the stove is switched off and doors are locked." → Answer: F. Obsessive compulsive disorder — Doubt with checking is one of the four common OCD presentations. [8]
Stem: Mrs. Chen, a construction site worker, fell from a rooftop in 2019 causing multiple rib fractures. Since then, she has recurrent shortness of breath and chest tightness when about to resume rooftop work. A doctor told her about panic disorder.
-
Q4 (6 marks): "Name three psychiatric symptoms she may have experienced."
- Markscheme: Fear of dying / losing control / going mad; palpitations; chest pain/tightness; choking sensation; dizziness; sweating; trembling; derealization/depersonalization; paresthesias; anticipatory anxiety. (Any 3 from DSM-5 panic attack criteria + anticipatory anxiety)
- Discriminator: Note this case has a clear situational trigger (returning to rooftop) — this might actually be better classified as a specific phobia or PTSD rather than "true" panic disorder (which should be unexpected/uncued). However, the question frames it as panic disorder.
-
Q5 (7 marks): "Develop a management plan for panic disorder in primary care while waiting for investigation results."
- Markscheme: (1) Psychoeducation about panic disorder; (2) Reassurance that physical symptoms are not dangerous; (3) Explain the fight-or-flight response; (4) Breathing/relaxation techniques; (5) Consider short-term benzodiazepine if severe; (6) Consider SSRI initiation; (7) Referral to psychiatry/psychology for CBT. [11]
Stem: "Characteristic features of a certain disorder include unpredictable attacks, signs reminiscent of myocardial infarction, and anticipatory anxiety, in the absence of severe stress. What is the MOST LIKELY diagnosis?"
Options: A. Agoraphobic disorder, B. Conversion disorder, C. Obsessive-compulsive disorder, D. Panic disorder
Answer: D. Panic disorder — Key discriminators: "unpredictable attacks" (= unexpected, uncued), "signs reminiscent of MI" (chest pain, palpitations), "anticipatory anxiety," and "absence of severe stress" (ruling out stress-related disorders). Agoraphobia would be situational, not unpredictable. [12]
Stem: "A 45-year-old woman presents at GOPC for low mood and fatigue for 6 months. She has difficulty falling asleep due to worry about health, muscle tension, weight gain of 5 kg, and loss of concentration. No suicidal ideation. Lives alone, few friends. Which symptom is MOST SUGGESTIVE of depression over GAD?"
Options: A. Difficulty falling asleep, B. Loss of concentration, C. Muscle tension, D. Weight gain
Answer: D. Weight gain — Difficulty falling asleep and loss of concentration occur in both. Muscle tension is more specific to GAD. Weight gain (or significant weight change) is a somatic feature more specific to depression. [9]
Stem: "It is not uncommon to have difficulties during interview with patients with anxiety disorder. Which technique would have a NEGATIVE impact during interviewing anxious patients?"
Options: A. Address the anxious feeling, B. Ask specific questions, C. Clarification and explanation, D. Give a diagnostic label
Answer: D. Give a diagnostic label — Labelling can increase stigma and anxiety. The other options are all appropriate interviewing techniques. [9]
Stem: "A 27-year-old bank teller presents with 3 months of worry about finances, girlfriend, parents' health, and own health. Trouble sleeping and controlling worries on most days. Restless, cannot sit still. GAD-7 score is 10. What is the severity level of his anxiety?"
Options: A. Mild Anxiety, B. Moderate Anxiety, C. No Anxiety, D. Severe Anxiety
Answer: B. Moderate Anxiety — GAD-7 score of 10 falls in the 10–14 range = Moderate. [10]
| Trap | How to Avoid |
|---|---|
| Confusing panic disorder with agoraphobia | Panic disorder = unexpected attacks. Agoraphobia = anxiety in specific situations (crowded, enclosed, away from home). Panic patients may develop agoraphobia secondarily. |
| Missing organic causes of anxiety | Always consider thyrotoxicosis, pheochromocytoma, cardiac arrhythmia, hypoglycaemia, substance intoxication/withdrawal before diagnosing primary anxiety disorder. |
| GAD vs Depression overlap | Weight change, early morning waking, diurnal variation, anhedonia, suicidal ideation → Depression. Muscle tension, future-oriented worry, difficulty falling asleep → GAD. Both share: poor concentration, fatigue, irritability, sleep disturbance. |
| OCD: obsessions vs delusions | Obsessions are ego-dystonic (recognised as own thoughts, resisted, felt as senseless). Delusions are ego-syntonic (believed to be true). If a patient loses insight → consider OCD with poor insight or psychotic disorder. |
| BZDs as long-term treatment | BZDs are short-term only. Long-term management = antidepressants (SSRIs/SNRIs). This is frequently tested. |
| Clomipramine vs Imipramine | Clomipramine = OCD. Imipramine = Panic disorder. Both are TCAs but have different primary indications. |
| Duration criteria | GAD: ≥6 months. Phobias: ≥6 months. Panic disorder: ≥1 month of concern after attack. OCD: no specific duration but > 1hr/day. |
| DSM-5 classification of OCD | OCD is no longer under "Anxiety Disorders" in DSM-5 — it has its own category. But the lecture (and exam) may still group it with anxiety disorders. |
High Yield Summary
Anxiety disorders are the most common mental disorders. The amygdala-based neurocircuit (amygdala → hypothalamus/brainstem for somatic symptoms; prefrontal cortex for cognitive control) is central. Three key neurotransmitter systems are dysregulated: GABA (↓ = loss of inhibition), norepinephrine (↑ = autonomic arousal), serotonin (dysregulation = mood/sleep/cognitive disturbance).
Somatic presentation is common and co-morbidity is common — always screen for depression and substance use.
Key disorders: (1) GAD = free-floating anxiety ≥6 months + ≥3 of 6 symptoms; (2) Panic Disorder = recurrent unexpected attacks + ≥1 month concern/behavioural change; (3) Specific Phobia = anxiety to specific object ≥6 months; (4) Agoraphobia = anxiety in ≥2 of 5 situations where escape is difficult; (5) Social Phobia = fear of negative evaluation in social situations; (6) OCD = ego-dystonic obsessions + compulsions, > 1hr/day, with maintained insight.
Treatment: First-line is CBT + SSRIs. Specific agents: Imipramine (panic), Clomipramine (OCD), Phenelzine/Moclobemide (phobia), Propranolol (somatic symptoms). BZDs are short-term only. ERP is the gold standard psychotherapy for OCD. Exposure therapy is key for phobias.
Exam priorities: Know DSM-5 criteria, differentiate panic disorder vs agoraphobia vs GAD, know GAD-7 cut-offs (10 = moderate), know why weight gain suggests depression over GAD, and never give a diagnostic label when interviewing anxious patients.
Active Recall - Anxiety Disorders
[1] Lecture slides: GC 167. I feel very nervous Anxiety disorders.pdf (all pages) [2] Senior notes: Ryan Ho Psychiatry.pdf (pages 170-181) [3] Lecture slides: GC 017. Common mental health problems in primary care.pdf (page 4) [4] Lecture slides: GC 171. Stress-related disorders and obsessive-compulsive disorder (Post-traumatic stress disorder adjustment disorder, acute stress disorder)_rev.pdf (pages 7, 42-43) [5] Lecture slides: CFB (PSY02) Classification and Diagnosis of Psychiatric Illness.pdf (page 40) [6] Lecture slides: Seminar 2 - Psychopathology - Dr Simon SY Lui_1_9_2025.pdf (page 14) [7] AOS material: AOS - Psych.md [8] Past papers: 2020 Fourth Summative Assessment MCQ paper.pdf (page 41, Q23-27) [9] Past papers: 2023 Fourth Summative MCQ.pdf (pages 28, 36 — Q75, Q95) [10] Past papers: 2024 Fourth Summative MCQ.pdf (page 28, Q77) [11] Past papers: 2021 Fourth Summative Minicase.pdf (page 22, Case Three) [12] Past papers: 2022 Fourth Summative MCQ.pdf (page 9, Q24)
GC166 I Cannot Help Myself, Taking These Pills Just Feels Good Substance Abuse And Addiction
Substance abuse and addiction is a chronic relapsing disorder characterized by compulsive drug seeking, continued use despite harmful consequences, and long-lasting neuroplastic changes in brain reward, motivation, and self-control circuits.
GC168 I Heard Those Newer Drugs Are Better Than My Current Psychiatric Medications
A clinical education session addressing patient concerns about switching established psychiatric medications to newer agents, emphasizing that newer psychotropic drugs are not inherently superior and that treatment decisions should be individualized based on efficacy, side-effect profiles, and patient response.